Dembure P P, Garrick M D
Blood. 1981 Jun;57(6):1125-31.
Hemoglobin beta-chain synthesis by rabbit erythroid cells was tested for dependence on availability of complementary alpha-chains. Reticulocytes and bone marrow cells were obtained from variant rabbits that have hemoglobin with isoleucine in alpha-chains but not in beta-chains. This characteristic permits the use of L-O-methylthreonine, a specific isoleucine antagonist, to inhibit selectively the synthesis of hemoglobin alpha-chains without directly affecting that of beta-chains. Study of hemoglobin synthesis by bone marrow cells presents two problems that require careful management: (A) the fragility of the globin-synthesizing apparatus and (B) the isolation of globin from the various proteins made by the mixture of nucleated cells. Disruption of synthetic activity was minimized by collecting the bone marrow in autologous plasma then removing fat and connective tissue while the cells were suspended in this medium. Purification involved gel filtration of hemoglobin and globin then CM-cellulose chromatography of globin chains. Absence of radioactive isoleucine in beta-chains demonstrated the efficacy of this scheme in removing isoleucine-containing proteins that otherwise elute with beta-chains on CM-cellulose columns. In reticulocytes, when synthesis of alpha-chains is inhibited by 30%--80%, that of beta-chains is stimulated by 20%--60%, but in marrow cells, incorporation into beta-chains stays at control level when alpha incorporation is inhibited. The data indicate that beta-chain synthesis is independent of the availability of complementary alpha-chains.
对兔红细胞生成细胞合成血红蛋白β链的过程进行了测试,以确定其是否依赖互补α链的可用性。网织红细胞和骨髓细胞取自变异兔,这些兔的血红蛋白α链中有异亮氨酸,而β链中没有。这一特性使得可以使用L-O-甲基苏氨酸(一种特异性异亮氨酸拮抗剂)来选择性抑制血红蛋白α链的合成,而不直接影响β链的合成。对骨髓细胞血红蛋白合成的研究存在两个需要谨慎处理的问题:(A)珠蛋白合成装置的脆弱性;(B)从有核细胞混合物产生的各种蛋白质中分离珠蛋白。通过将骨髓收集在自体血浆中,然后在细胞悬浮于该培养基时去除脂肪和结缔组织,可将合成活性的破坏降至最低。纯化过程包括对血红蛋白和珠蛋白进行凝胶过滤,然后对珠蛋白链进行CM-纤维素色谱分析。β链中不存在放射性异亮氨酸,证明了该方案在去除含异亮氨酸蛋白质方面的有效性,否则这些蛋白质会在CM-纤维素柱上与β链一起洗脱。在网织红细胞中,当α链合成被抑制30% - 80%时,β链合成会被刺激20% - 60%,但在骨髓细胞中,当α链掺入被抑制时,β链的掺入保持在对照水平。数据表明,β链合成不依赖于互补α链的可用性。